 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
InteRNA Gets Nod for US Patent, Plans IND for miRNA Melanoma Drug in Late 2013
October 25, 2012
InteRNA Gets Nod for US Patent, Plans IND for miRNA Melanoma Drug in Late 2013
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Novartis, Tekmira, and More
May 21, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Santaris, Nitto Denko, BASF, and More
May 16, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Merck, DuPont, MIT, and More
May 9, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Idera, Silence, OSU, and More
May 2, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Dicerna, Merck, Somagenics, and More
April 25, 2013 / Gene Silencing News